| Name | Title | Contact Details |
|---|
Fort Hudson Nursing Home Inc is a Fort Edward, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
Lourdes has as many faces as there are people in the community it serves. With its spiritual Catholic faith, Lourdes Hospital has provided compassionate care to those in need since 1925. In Binghamton, NY, our health system includes an Ambulatory Surgery Center, Home Care and Hospice services, and a Regional Cancer Center. Reaching beyond these boundaries, Lourdes has established a network of primary care physicians at convenient sites throughout the region. Our Mission In Motion program, provides women`s health services with a mobile medical van, making health care accessible to rural populations.
Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Zynx Health, a subsidiary of Hearst Corporation, is the market leader in providing evidence-based and experience-based clinical decision support solutions proven to measurably improve the quality, safety, and efficiency of patient care.